● Recruiting

A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

Condition: Atrial Fibrillation · Sponsor: Novartis Pharmaceuticals

PhasePhase 2

Planned participants165

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

A randomized, placebo-controlled, participant-and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden as well as the safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · 1-888-669-6682 · novartis.email@novartis.com

Novartis Pharmaceuticals · +41613241111

Always discuss trial participation with your own doctor first.

Locations (38)

Cardiology Associates of North MS	Tupelo, Mississippi, United States	Recruiting
Weill Cornell Medical Center	New York, New York, United States	Recruiting
Duke Univ Medical Center	Durham, North Carolina, United States	Recruiting
Intermountain Medical Center	Murray, Utah, United States	Recruiting
Swedish Heart and Vascular Clinic	Seattle, Washington, United States	Recruiting
Novartis Investigative Site	Calgary, Alberta, Canada	Recruiting
Novartis Investigative Site	Vancouver, British Columbia, Canada	Recruiting
Novartis Investigative Site	Hamilton, Ontario, Canada	Recruiting
Novartis Investigative Site	London, Ontario, Canada	Recruiting
Novartis Investigative Site	Newmarket, Ontario, Canada	Recruiting
Novartis Investigative Site	Toronto, Ontario, Canada	Recruiting
Novartis Investigative Site	Toronto, Ontario, Canada	Recruiting

+ 26 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07217067